Gastric cancer (CG) is one the most common cancers worldwide, which is usually diagnosed at late stage since it is asymptomatic in early stages (
1,
2). Tumor resection and surgery are the only effective strategies to treat it, while chemotherapy has proven ineffective in this regard (
3). Molecular targeted therapies of cancers have been proposed in recent decades as alternative treatment methods. However, it is necessary to identify the involved molecular pathways before designing novel and specific therapeutics methods for each cancer (
4).
Long non-coding RNAs (lncRNAs) are defined as lengthy transcripts (larger than 200 nt) lacking protein-coding capacity (
5). The involvement of lncRNAs in broad spectrum of biological processes such as cell cycle, growth, differentiation, and apoptosis has been reported (
6). Aberrant expressions of lncRNAs have been found in a variety of human tumors, suggesting that these non-coding transcripts are potential biomarkers of cancers (
7). The HOX antisense intergenic RNA (HOTAIR) is an oncogenic lncRNAs playing a critical role in promotion, progression, and invasion of variety of human cancers (
8). The involvement is well-defined and established (
9). It has been reported that silencing of
HOTAIR exerts an anti-tumor effect on gastric cancer and potentially inhibits cell growth (
10). Epithelial-mesenchymal transition (EMT) is a cellular process whereby epithelial cells lose their characteristics and obtain mesenchymal phenotypes. Following EMT, epithelial cells lose cell-cell joints, polarity, and epithelial markers, and then non-motile epithelial cells gain cell motility, a spindle-cell shape, and presenting mesenchymal markers (
11). Epithelial-mesenchymal transition trigger the cancer metastatic cascade through different signaling pathways (
12). Claudins are structural and functional elements of tight junction playing an important role during EMT (
13). Dysregulation expression of claudins has been reported in several human tumors, and the pattern depends on claudins isoform or cancer type (
14). Loss of function of these proteins affect the cell-cell adhesions and prepare the cellular micro environment toward malignant transformation (
15). Fibronectin (FN) is an abundant extracellular matrix (ECM) glycoprotein that functions during tissue repair (
16). Altered expression of fibronectin in various human tumors proposed them as promoters of cancer progression and metastasis (
17).